Ranolazine
- Product NDC
- 59651-009
- 11-digit product format
- 596510009
- Labeler code
- 59651
- Product ID
- 59651-009_ee3c2383-a36a-4abe-9764-89f817798f28
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranolazine
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Aurobindo Pharma Limited
- Application
- ANDA209081
- Marketing category
- ANDA
- Marketing start
- 2022-12-23
- Substance
- RANOLAZINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| unfinished product | product | 59651-009 | UNFINISHED | Active or certified unfinished drug listing | 2026-08-17 | ||
| unfinished package | package | 59651-009 | 59651-009-15 | UNFINISHED | Active or certified unfinished drug listing | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 21:27 UTC · source 2025-12-05 | unfinished product | product | a6255e0c9aa5… | a0211a219f2e… | |
| 2025-12-14 21:27 UTC · source 2025-12-05 | unfinished package | package | 59651-009-15 | a6255e0c9aa5… | a0211a219f2e… |
| 2025-08-26 23:59 UTC · source 2025-08-26 | unfinished product | product | 1d862106b807… | 00c93037cd84… | |
| 2025-08-26 23:59 UTC · source 2025-08-26 | unfinished package | package | 59651-009-15 | 1d862106b807… | 00c93037cd84… |
| 2025-05-15 14:59 UTC · source 2025-05-14 | unfinished product | product | 390b4c401c3f… | 2c692c2daee3… | |
| 2025-05-15 14:59 UTC · source 2025-05-14 | unfinished package | package | 59651-009-15 | 390b4c401c3f… | 2c692c2daee3… |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished product | product | e30019b0c005… | a3f0b14938b7… | |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished package | package | 59651-009-15 | e30019b0c005… | a3f0b14938b7… |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished product | product | bbbc9f937eca… | 946b9c97cf81… | |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 59651-009-15 | bbbc9f937eca… | 946b9c97cf81… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 59651-009-15 | f268b84574a6… | 26285f5ac5df… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | f764e8902f78… | 92046438deef… | |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished package | package | 59651-009-15 | f764e8902f78… | 92046438deef… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished package | package | 59651-009-15 | 68b1e3bced9e… | 98a755eb8bc6… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 59651-009-15 | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 59651-009-15 | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 59651-009-15 | 27f29a85d7e4… | 1372111e901f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 59651-009-15 | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 59651-009-15 | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 59651-009-15 | 50b4072663b7… | eae3003ed65e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209081-001 | RANOLAZINE | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | |
| A209081-002 | RANOLAZINE | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209081-001 | AB |
| A209081-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209081-001 | RANOLAZINE | 500MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209081-002 | RANOLAZINE | 1GM | TABLET, EXTENDED RELEASE / ORAL | AB | 2022-12-23 | 9b2671bbb829… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A209081-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A209081-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A209081-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209081-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209081-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209081-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209081-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209081-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209081-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209081-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209081-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209081-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209081-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209081-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209081-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209081-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209081-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209081-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209081-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A209081-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A209081-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A209081-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209081-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A209081-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209081-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A209081-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209081-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A209081-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A209081-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A209081-002 | AB | 1 | 8072bd15b7f6… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209081-001 | AB | 1 | 6a51e52b5d6a… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209081-002 | AB | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A209081-001 | AB | 1 | 1c564ffb4f44… |
| 2024-02-18 07:12 UTC | 2024-02 | A209081-002 | AB | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A209081-001 | AB | 1 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209081-002 | AB | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209081-001 | AB | 1 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209081-002 | AB | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209081-001 | AB | 1 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209081-002 | AB | 1 | 9b2671bbb829… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ranolazine
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| RANOLAZINE | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| A6IEZ5M406 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 49873158-5c0a-41da-86a2-369ef6b0cbc8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 4367aed1-e488-b72c-d0ec-178a4e054129 | Product name | 9 | 20250624 |
| ddc83a74-720a-4975-8550-c4bd979c9094 | Product name | 1 | 20221212 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59651-009-18 | Ranolazine | 180 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 180 | 2 | |
| 59651-009-60 | Ranolazine | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | 2 | |
| 59651-009-99 | Ranolazine | 1000 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 1000 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59651-009-60 | EA - Each | 59651-009 | 5ace4ae7-6540-4b59-993d-f5b4eb838fd7 | 1 | 2023-04-07 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ranolazine | RANOLAZINE | Aurobindo Pharma Limited | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2024-02-15 | Warnings, Adverse reactions | 209081 ANDA209081 59651-009 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 728231 | ranolazine 1000 MG 12HR Extended Release Oral Tablet | PSN | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2 |
| 616749 | ranolazine 500 MG 12HR Extended Release Oral Tablet | PSN | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2 |
| 728231 | 12 HR ranolazine 1000 MG Extended Release Oral Tablet | SCD | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2 |
| 616749 | 12 HR ranolazine 500 MG Extended Release Oral Tablet | SCD | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2 |
| 728231 | ranolazine 1000 MG 12 HR Extended Release Oral Tablet | SY | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2 |
| 616749 | ranolazine 500 MG 12 HR Extended Release Oral Tablet | SY | 49873158-5c0a-41da-86a2-369ef6b0cbc8 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 59651-009-15 | 59651000915 | 1500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BAG (59651-009-15) | 23-DEC-22 | Current | |||
| 59651-009-18 | 59651000918 | 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-18) | 2022-12-23 | 0000-00-00 | No | No | Current |
| 59651-009-60 | 59651000960 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-60) | 2022-12-23 | 0000-00-00 | No | No | Current |
| 59651-009-99 | 59651000999 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-99) | 2022-12-23 | 0000-00-00 | No | No | Current |